We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Centrifugal Speed Affects Light Transmission Aggregometry

By LabMedica International staff writers
Posted on 02 Jan 2012
Light transmission aggregometry (LTA) is considered the gold standard for investigating platelet activity ex vivo, but LTA protocols are not standardized.

Centrifugation speed is an essential component of platelet preparation in LTA and has yet to be standardized, which may affect platelet aggregation leading to a potential source of variance in results. More...


In a study, conducted at the New York University School of Medicine (NY, USA) the effect of relative centrifugal force (RCF) intensity on LTA results was investigated. Ten healthy controls had venous blood drawn and centrifuged at 150, 200, 300, and 500 × g for 10 minutes. Cell counts in whole blood and platelet-rich plasma (PRP) were measured using a hematology analyzer. LTA was performed using 1.0 µM adenosine diphosphate (ADP) and 0.4 µM epinephrine as an agonist. The percentage of aggregation was compared at 60, 120, 180, and 300 seconds and at maximum aggregation.

Centrifugation speed was associated with a statistically significant decrease in platelet counts and decrease in mean platelet volume in PRP. Consistently, platelet aggregation in response to 0.4 µM of epinephrine decreased significantly with increasing centrifuge RCF at 60, 120, 180, 300 seconds and at maximum aggregation. Whole blood and PRP cell blood count were performed using a Sysmex XE-2100 analyzer (Mundelein, IL, USA). LTA was performed using the AggRAM light transmission aggregometer, reagents, cuvettes, and stir bars (Helena Laboratories, Beaumont, TX, USA).

The authors concluded that using different centrifuge RCF results in changes in PRP properties and LTA. This difference in methodology gives pause to comparing LTA from studies with different protocols and may help explain some of the inconsistencies observed in the field. Consequently, consideration should be given to standardize centrifugation parameters in performing LTA. The study is planned to appear in the February 2012 print edition of the International Journal of Laboratory Hematology.

Related Links:
New York University School of Medicine
Sysmex
Helena Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Test
Allplex HPV28 Detection
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.